CDCA8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.66267000167863E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.18820000902542E-09 |
Normal-vs-Stage2 |
7.160500E-04 |
Normal-vs-Stage3 |
3.96520000001122E-06 |
Normal-vs-Stage4 |
5.79210002182862E-09 |
Stage1-vs-Stage2 |
4.749800E-01 |
Stage1-vs-Stage3 |
2.270200E-02 |
Stage1-vs-Stage4 |
3.68969999999802E-05 |
Stage2-vs-Stage3 |
1.817200E-01 |
Stage2-vs-Stage4 |
1.320900E-03 |
Stage3-vs-Stage4 |
4.775800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.65201186064223E-12 |
Normal-vs-AfricanAmerican |
4.104400E-03 |
Normal-vs-Asian |
1.477810E-01 |
Caucasian-vs-AfricanAmerican |
1.982620E-03 |
Caucasian-vs-Asian |
4.621000E-01 |
AfricanAmerican-vs-Asian |
2.643800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
8.62088178621434E-13 |
Normal-vs-Female |
1.80640002955812E-09 |
Male-vs-Female |
3.907800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.921600E-03 |
Normal-vs-Age(41-60Yrs) |
2.81819999559119E-08 |
Normal-vs-Age(61-80Yrs) |
3.24540394558426E-12 |
Normal-vs-Age(81-100Yrs) |
8.157000E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.243800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.345600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.346370E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.290200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.786000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.068000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.922440E-02 |
Normal-vs-Grade 2 |
1.69609992717312E-10 |
Normal-vs-Grade 3 |
1.47369999536906E-08 |
Normal-vs-Grade 4 |
4.66049999703344E-08 |
Grade 1-vs-Grade 2 |
7.782200E-03 |
Grade 1-vs-Grade 3 |
2.607400E-04 |
Grade 1-vs-Grade 4 |
1.93459999997536E-06 |
Grade 2-vs-Grade 3 |
2.644500E-02 |
Grade 2-vs-Grade 4 |
7.65360000000159E-05 |
Grade 3-vs-Grade 4 |
3.283800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.46950000004631E-07 |
Normal-vs-ccB subtype |
2.74400002719943E-09 |
ccA subtype-vs-ccB subtype |
1.036800E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.63339997083511E-09 |
Normal-vs-N1 |
1.365030E-04 |
N0-vs-N1 |
1.164830E-03 |
|
|